Valuation Alkem Laboratories Limited

Stocks

Market Closed - NSE India S.E. 12:05:07 01/10/2026 BST			5-day change	1st Jan Change
5,220.00 ^INR	+1.09%		-1.02%	-5.20%

09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer	CI
09-24	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Key Managerial Personnel and Senior Management Personnel, Effective September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	432,909	406,055	590,890	583,680	633,575	624,129	-	-
Change	-	-6.2%	45.52%	-1.22%	8.55%	-1.49%	-	-
Enterprise Value (EV) ¹	433,805	393,853	587,236	578,678	632,481	611,050	596,071	587,268
Change	-	-9.21%	49.1%	-1.46%	9.3%	-3.39%	-2.45%	-1.48%
P/E	26.3x	41.3x	32.9x	27x	27.5x	27.2x	23.6x	20.4x
PBR	5.01x	4.49x	5.73x	4.87x	4.58x	4.04x	3.57x	3.15x
PEG	-	-1x	0.4x	1.3x	4.37x	-72.71x	1.6x	1.3x
Capitalization / Revenue	4.07x	3.5x	4.66x	4.5x	4.31x	3.74x	3.36x	3.05x
EV / Revenue	4.08x	3.4x	4.64x	4.46x	4.3x	3.66x	3.21x	2.87x
EV / EBITDA	21.1x	24.5x	26.2x	23x	21x	17.9x	15.2x	13.2x
EV / EBIT	24.8x	30.3x	30.2x	26.9x	24.1x	20.6x	17.5x	15x
EV / FCF	55.4x	27.1x	33.3x	45.3x	42.8x	59.3x	29.2x	23x
FCF Yield	1.81%	3.69%	3%	2.21%	2.33%	1.69%	3.43%	4.35%
Dividend per Share ²	34	25	40	45	53	49.33	55.28	63.37
Rate of return	0.94%	0.74%	0.81%	0.92%	1%	0.95%	1.06%	1.21%
EPS ²	137.6	82.31	150.2	181.1	192.5	191.8	220.9	256
Distribution rate	24.7%	30.4%	26.6%	24.8%	27.5%	25.7%	25%	24.8%
Net sales ¹	106,342	115,993	126,676	129,645	147,123	166,957	185,727	204,703
EBITDA ¹	20,529	16,094	22,455	25,122	30,052	34,191	39,311	44,365
EBIT ¹	17,490	12,990	19,462	21,550	26,232	29,618	34,111	39,074
Net income ¹	16,456	9,842	17,958	21,655	23,018	23,072	27,021	31,030
Net Debt ¹	896.1	-12,202	-3,654	-5,003	-1,094	-13,079	-28,058	-36,861
Reference price ²	3,620.70	3,396.10	4,942.00	4,881.70	5,299.00	5,220.00	5,220.00	5,220.00
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,565	-	-
Announcement Date	13/05/22	19/05/23	29/05/24	29/05/25	28/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALKEM LABORATORIES LIMITED	27.22x	3.66x	17.87x	0.94%	6.49B
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.67x	6.24x	17.33x	2.15%	370.37B
Weighted average by Cap.	31.79x	7.60x	18.60x	1.96%